Selective serotonin reuptake inhibitors and autism: additional data on the Quebec Pregnancy/Birth Cohort

Am J Obstet Gynecol. 2016 Dec;215(6):803-805. doi: 10.1016/j.ajog.2016.08.021. Epub 2016 Aug 31.

Authors

Anick Bérard¹, Takoua Boukhris², Odile Sheehy³

Affiliations

¹ Faculty of Pharmacy, University of Montreal, Montreal, Quebec, Canada; Research Center, Centre hospitalier universitaire Sainte-Justine, Montreal, Quebec, Canada. Electronic address: anick.berard@umontreal.ca.
² Faculty of Pharmacy, University of Montreal, Montreal, Quebec, Canada; Research Center, Centre hospitalier universitaire Sainte-Justine, Montreal, Quebec, Canada.
³ Research Center, CHU Sainte-Justine, Montreal, Quebec, Canada.

PMID: 27589900
DOI: 10.1016/j.ajog.2016.08.021

No abstract available

Publication types

Letter
Research Support, Non-U.S. Gov't

MeSH terms

Autistic Disorder / epidemiology*
Depression / complications
Depression / drug therapy*
Female
Humans
Pregnancy
Pregnancy Complications / drug therapy*
Quebec
Risk Factors
Selective Serotonin Reuptake Inhibitors / adverse effects*
Selective Serotonin Reuptake Inhibitors / therapeutic use

Substances

Serotonin Uptake Inhibitors

Grants and funding

132750/CIHR/Canada